Hatice Odabaş

Akademisyen

Alan: Tıp
Üniversite: Sağlık Bilimleri Üniversitesi
Fakülte ve Bölüm: İstanbul Kartal Dr. Lütfi Kırdar Şehir Sağlık Uygulama ve Araştırma Merkezi

Bu Sayfa Senin mi?

Sayfanı sahiplenirsen bilgilerini kendin güncelleyebilir, okurlardan mesaj alabilirsin.

Bir hata mı var?

Bu sayfa henüz sahiplenilmedi. İletişim bilgisi gösterilmiyor.

Bu sayfadaki bilgiler kamuya açık kaynaklardan derlendi.

Akademik Profiller

ORCID

Yayınlar

Tüm Yayınlar

1
Single-Center Real World Study of Everolimus and Exemestane in HR+/HER2− Metastatic Breast Cancer Following CDK4/6 Inhibitor TherapyCurrent Oncology
2025
2
Oncolytic Therapies for Glioblastoma: Advances, Challenges, and Future PerspectivesCancers
2025
3
Effect of Family and Personal Medical History on Treatment Outcomes of Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC)Healthcare
2025
4
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World DataJournal of Clinical Medicine
2025
5
Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast CancerPharmaceuticals
2025
6
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric CancerMedicina
2025
7
Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab EmtansineMedicina
2025
8
Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational StudyMedicina
2025
9
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter StudyMedicina
2025
10
The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter StudyMedicina
2025

Yayın listesi ORCID kaydından alındı.